TrialScientific reports2021

Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer.

Ho Hyun Ryu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.